OncoCyte Corporation
(OCX)
undefined
undefined%
At close: undefined
2.32
-0.85%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 1.50M | 958.00K | 7.73M | 1.22M | - | - | - | - | - | - | - |
Cost of Revenue | 1.09M | 976.00K | 7.54M | 1.85M | 344.00K | 559.00K | 580.00K | 387.00K | 283.00K | - | - |
Gross Profit | 413.00K | -18.00K | 188.00K | -639.00K | -344.00K | -559.00K | -580.00K | -387.00K | -283.00K | - | - |
Operating Income | -25.14M | -18.00M | -46.95M | -29.71M | -22.24M | -15.20M | -18.85M | -11.14M | -8.72M | -4.97M | -3.50M |
Interest Income | - | 77.00K | 209.00K | 252.00K | 299.00K | - | - | - | - | - | - |
Pretax Income | -24.86M | -18.61M | -73.36M | -31.19M | -22.43M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.50M |
Net Income | -27.78M | -73.44M | -64.10M | -29.93M | -22.33M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.50M |
Selling & General & Admin | 13.54M | 23.01M | 33.50M | 23.28M | 15.45M | 8.69M | 11.68M | 5.46M | 4.19M | 1.01M | 552.00K |
Research & Development | 9.29M | 7.30M | 13.63M | 9.80M | 6.79M | 6.51M | 7.17M | 5.68M | 4.53M | 3.96M | 2.94M |
Other Expenses | 2.72M | -67.00K | -37.00K | 27.00K | -3.00K | 91.00K | - | - | 2.00K | -11.00K | - |
Operating Expenses | 25.64M | 30.31M | 47.13M | 33.08M | 22.24M | 15.20M | 18.85M | 11.14M | 8.72M | 4.97M | 3.50M |
Interest Expense | 52.00K | 77.00K | 209.00K | 252.00K | 299.00K | 216.00K | 217.00K | 28.00K | 19.00K | 2.00K | - |
Selling & Marketing Expenses | 2.79M | 1.13M | 11.17M | 6.49M | 2.16M | 1.68M | 2.44M | 1.20M | 324.00K | - | - |
Cost & Expenses | 26.64M | 31.29M | 54.67M | 34.94M | 22.24M | 15.20M | 18.85M | 11.14M | 8.72M | 4.97M | 3.50M |
Income Tax | - | 54.83M | -9.26M | -1.25M | -97.00K | -336.00K | 217.00K | -387.00K | -262.00K | -9.00K | - |
Shares Outstanding (Basic) | 7.65M | 5.54M | 4.45M | 3.27M | 2.56M | 1.89M | 1.51M | 1.33M | 1.05M | 324.62K | 324.62K |
Shares Outstanding (Diluted) | 7.65M | 5.54M | 4.45M | 3.27M | 2.56M | 1.89M | 1.51M | 1.33M | 1.05M | 324.62K | 324.62K |
EPS (Basic) | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 | -10.77 |
EPS (Diluted) | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 | -10.77 |
EBITDA | -23.12M | -13.31M | -48.46M | -30.54M | -21.89M | -15.20M | -18.27M | -11.14M | -8.44M | -4.69M | -3.22M |
Depreciation & Amortization | 1.68M | 5.22M | 4.21M | 394.00K | 344.00K | 559.00K | 580.00K | 387.00K | 283.00K | 281.00K | 277.00K |